论文期刊

取消

高级检索

检索历史清除

首页> Clinical breast cancer> Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.

Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.

导出原文传递

翻译打印收藏纠错

作者： Yuko,Takahashi ^[1] ; Takayuki,Iwamoto ^[2] ; Yoko,Suzuki ^[3] ; Yukiko,Kajiwara ^[3] ; Minami,Hatono ^[1] ; Takahiro,Tsukioki ^[1] ; Kengo,Kawada ^[1] ; Mariko,Kochi ^[3] ; Hirokuni,Ikeda ^[1] ; Tadahiko,Shien ^[1] ; Naruto,Taira ^[1] ; Junji,Matsuoka ^[4] ; Hiroyoshi,Doihara ^[1] ; Shinichi,Toyooka ^[1]

作者单位： Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan. ^[1] Departments of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan. Electronic address: tiwamoto@md.okayama-u.ac.jp. ^[2] Departments of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan. ^[3] Departments of Palliative and Supportive Medicine, Okayama University Hospital, Okayama, Japan. ^[4]

关键词 Gene expression Hormone receptor positive Residual tumor burden Targeted therapy Triple negative

主题词抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳房(Breast);乳腺肿瘤(Breast Neoplasms);化学疗法, 辅助(Chemotherapy, Adjuvant);女(雌)性(Female);基因表达谱(Gene Expression Profiling);人类(Humans);中年人(Middle Aged);分子靶向治疗(Molecular Targeted Therapy);肿瘤辅助疗法(Neoadjuvant Therapy);肿瘤, 残余(Neoplasm, Residual);寡核苷酸序列分析(Oligonucleotide Array Sequence Analysis);回顾性研究(Retrospective Studies);肿瘤负荷(Tumor Burden)

DOI 10.1016/j.clbc.2019.07.001

PMID 31570267

发布时间 2021-03-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览4

Clinical breast cancer

Clinical breast cancer

2020年20卷2期

117-124.e4页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览4

Clinical breast cancer

点击下载本期目录封面

Clinical breast cancer

2020年20卷2期

117-124.e4页

相关期刊

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷